A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy

被引：0
|
作者：
M Tanioka
A Kitao
K Matsumoto
N Shibata
S Yamaguchi
K Fujiwara
H Minami
N Katakami
S Morita
S Negoro
机构：
[1] Medical Oncology,Department of Pharmacy
[2] Hyogo Cancer Center,Division of Pulmonary Medicine
[3] Medical Oncology/Hematology,undefined
[4] Kobe University Graduate School of Medicine,undefined
[5] Hyogo Cancer Center,undefined
[6] Gynecologic Oncology,undefined
[7] Hyogo Cancer Center,undefined
[8] Kobe City Medical Center General Hospital,undefined
来源：
British Journal of Cancer | 2013年 / 109卷
关键词：
aprepitant; moderately emetogenic chemotherapy; carboplatin; female; alcohol use;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：859 / 865
页数：6
相关论文
共 50 条
  • [1] A randomised, placebo-controlled, double-blind study of aprepitant in nondrinking women younger than 70 years receiving moderately emetogenic chemotherapy
    Tanioka, M.
    Kitao, A.
    Matsumoto, K.
    Shibata, N.
    Yamaguchi, S.
    Fujiwara, K.
    Minami, H.
    Katakami, N.
    Morita, S.
    Negoro, S.
    BRITISH JOURNAL OF CANCER, 2013, 109 (04) : 859 - 865
  • [2] Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial
    Bakhshi, Sameer
    Batra, Atul
    Biswas, Bivas
    Dhawan, Deepa
    Paul, Reeja
    Sreenivas, Vishnubhatla
    SUPPORTIVE CARE IN CANCER, 2015, 23 (11) : 3229 - 3237
  • [3] Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial
    Sameer Bakhshi
    Atul Batra
    Bivas Biswas
    Deepa Dhawan
    Reeja Paul
    Vishnubhatla Sreenivas
    Supportive Care in Cancer, 2015, 23 : 3229 - 3237
  • [4] Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Randomized, Double-Blind, Placebo-Controlled Study
    Mizukami, Naomi
    Yamauchi, Masanori
    Koike, Kazuhiko
    Watanabe, Akihiko
    Ichihara, Koji
    Masumori, Naoya
    Yamakage, Michiaki
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2014, 47 (03) : 542 - 550
  • [5] APREPITANT AS AN ADD-ON THERAPY IN CHILDREN RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL
    Bakhshi, S.
    Batra, A.
    Biswas, B.
    Dhawan, D.
    Paul, R.
    Sreenivas, V.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S238 - S238
  • [6] Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin
    Hideaki Yahata
    Hiroaki Kobayashi
    Kenzo Sonoda
    Mototsugu Shimokawa
    Tatsuhiro Ohgami
    Toshiaki Saito
    Shinji Ogawa
    Kunihiro Sakai
    Akimasa Ichinoe
    Yousuke Ueoka
    Yasuyuki Hasuo
    Makoto Nishida
    Satohiro Masuda
    Kiyoko Kato
    International Journal of Clinical Oncology, 2016, 21 : 491 - 497
  • [7] Efficacy of aprepitant for the prevention of chemotherapy-induced nausea and vomiting with a moderately emetogenic chemotherapy regimen: a multicenter, placebo-controlled, double-blind, randomized study in patients with gynecologic cancer receiving paclitaxel and carboplatin
    Yahata, Hideaki
    Kobayashi, Hiroaki
    Sonoda, Kenzo
    Shimokawa, Mototsugu
    Ohgami, Tatsuhiro
    Saito, Toshiaki
    Ogawa, Shinji
    Sakai, Kunihiro
    Ichinoe, Akimasa
    Ueoka, Yousuke
    Hasuo, Yasuyuki
    Nishida, Makoto
    Masuda, Satohiro
    Kato, Kiyoko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2016, 21 (03) : 491 - 497
  • [8] A randomized, double-blind, placebo-controlled study of the safety and efficacy of olanzapine for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
    Jeon, So Yeon
    Han, Hye Sook
    Bae, Woo Kyun
    Park, Moo-Rim
    Lee, Sang-Cheol
    Go, Se-Ii
    Yun, Hwan Jung
    Ryu, Hyewon
    Im, Yong-Jin
    Song, Eun-Kee
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia
    Pizzolato, G
    Cagnin, G
    Mancia, D
    Caffarra, P
    Avanzi, S
    Copelli, S
    Ciappina, C
    Lo Presti, F
    Spilimbergo, PG
    D'Antonio, E
    Di Costanzo, E
    Matrango, M
    Pastres, P
    Urbani, PP
    Signorino, M
    Simoncelli, M
    Provinciali, L
    Regnicolo, L
    Albano, C
    Roccatagliata, G
    Rubino, V
    Cultrera, S
    Fracassi, M
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1997, 47 (11A): : 1329 - 1331
  • [10] A phase II randomized double-blind placebo-controlled study of 6-gingerol as an anti-emetic in solid tumor patients receiving moderately to highly emetogenic chemotherapy
    J. Konmun
    K. Danwilai
    N. Ngamphaiboon
    B. Sripanidkulchai
    A. Sookprasert
    S. Subongkot
    Medical Oncology, 2017, 34
12345